bivv020
Showing 1 - 2 of 2
Immune Thrombocytopenia (ITP) Trial in Worldwide (BIVV020)
Active, not recruiting
- Immune Thrombocytopenia (ITP)
- BIVV020
-
Washington, District of Columbia
- +8 more
May 3, 2022
Transplant Rejection Trial in Worldwide (BIVV020, Intravenous immunoglobulin (IVIg), Rituximab)
Recruiting
- Transplant Rejection
- BIVV020
- +6 more
-
Westmead, New South Wales, Australia
- +14 more
Aug 2, 2022